Please assess the completion status of the following clinical trial:

Trial Title: Dexmedetomidine Pharmacokinetics-pharmacodynamics in Mechanically Ventilated Children With Single-organ Respiratory Failure

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients (m/f) admitted to the paediatric intensive care unit~* expected to require at least 24h of mechanical ventilation~* patient age : 1 month-15 years~* patients with single-organ respiratory failure~Exclusion Criteria:~* patients with neurologic conditions that prohibit an evaluation of adequate analgosedation~* no arterial catheter in place at inclusion~* patients who have received another investigational drug within 30 days~* patients on continuous infusion with neuromuscular blockers~* patients with a life expectancy \<72h~* patients with a known allergy to lorazepam, midazolam and/or morphine~* heart block~* pre-existing bradycardia~* hemodynamically unstable patients (Wernovsky index \> 16 points) after full fluid replacement with crystalloid~* patients with significant renal insufficiency (creatinine plasma level 1 month-5 year : \> 1 mg/dl ; 5-10 years : \>1.2 mg/dl; \> 10 years : \> 1.5 mg/dl)~* patients with significant hepatic insufficiency (aspartate aminase \>950 UI/L and prothrombin time \< 60 or INR \>1.4)~* previous treatment with α2-adrenoreceptor agonist clonidine within 14 days

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 15 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).